Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84
United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David Edward Johnson
25 Nov 2025
Director
Buy indirect
27,532
$43.12
$1.19M

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 10
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 4,810,436
History held since 6 Oct 2006